As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Boston Scientific: Concurrent Investment Advisors LLC, Wealth Enhancement Advisory Services LLC, Quaker Wealth Management LLC, Jane Street Group LLC, Goldman Sachs Group Inc., Millennium Management LLC, Cubist Systematic Strategies LLC, Nomura Holdings Inc., Susquehanna International Group LLP, HAP Trading LLC, BNP Paribas Financial Markets, Eisler Capital Management Ltd., PEAK6 LLC, Jane Street Group LLC, Walleye Trading LLC, Walleye Capital LLC, Capital Fund Management S.A., Hsbc Holdings PLC, Simplex Trading LLC, JPMorgan Chase & Co., Citigroup Inc., XY Capital Ltd, Delta Accumulation LLC, Readystate Asset Management LP, Allianz Asset Management GmbH, Portman Square Capital LLP, and Caas Capital Management LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.